UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Tbilisi explosion leaves four dead, child rescued alive

Kushner: Trump prefers peace over profits

Azerbaijan marks 35 years since Garakand helicopter tragedy

Ilham Aliyev met with Prime Minister of Vietnam

Six years pass since Aghdam's return to Azerbaijan

Aliyev visited Ho Chi Minh Mausoleum in Hanoi - Photo

Zelensky calls for four-way peace talks with Russia

Aliyev visited Revolutionary Martyrs Memorial in Hanoi - Photo

Lukashenko: Presidents should not swear at subordinates

Trump says he is in no rush to decide on Iran

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla